MACROBID

This brand name is authorized in United States. It is also authorized in Canada, Ireland, Israel, New Zealand, UK.

Active ingredients

The drug MACROBID contains one active pharmaceutical ingredient (API):

1	Nitrofurantoin UNII 927AH8112L - NITROFURANTOIN
	Nitrofurantoin is a broad spectrum antibacterial agent, active against the majority of urinary pathogens. It is bactericidal in renal tissue and throughout the urinary tract. The wide range of organisms sensitive to the bacterial activity include Escherichia coli, Enteroccus faecalis, Klebsiella species, Enterobacter species, Staphylococcus species: (e.g. S. aureus, S. saprophyticus, S. epidermidis).
	Read more about Nitrofurantoin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MACROBID Capsule	MPI, US: SPL/Old	FDA, National Drug Code (US)
MACROBID Prolonged-release capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XE01	Nitrofurantoin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XE Nitrofuran derivatives
Discover more medicines within J01XE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02063662
GB	Medicines & Healthcare Products Regulatory Agency	23528, 373882
IE	Health Products Regulatory Authority	32457
IL	מִשְׂרַד הַבְּרִיאוּת	9371
NZ	Medicines and Medical Devices Safety Authority	18057
US	FDA, National Drug Code	52427-285, 70518-2531